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Précis
Financial toxicity and family building difficulties may co-occur in young adult cancer survivors.
We describe this intersection and propose steps to alleviate associated distress.
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The convergence of financial toxicity and family building difficulties after cancer creates
unique challenges for young adult (YA; 18-39 years old) cancer survivors. Financial toxicity,
the economic distress or hardship resulting from cancer treatment, has been reported among
YA survivors at alarming rates; at the same time, YAs who experience fertility impairment as
a result of treatment may additionally face costly family building options. These combined
financial pressures can have significant effects on family building decisions and financial
outcomes in both the short- and long-term. Here, we describe how financial toxicity and
fertility-related side effects of treatment can co-occur among YA cancer survivors and
propose steps to alleviate distress associated with this intersection.

Financial Toxicity of Cancer in Young Adults
Author Manuscript

Researchers have come to view financial toxicity as yet another treatment-related effect, in
the same vein as common biological toxicities.1 It is rooted, in part, in the high cost of
treatment and medication; the impact of disease and treatment on the ability to work and/or
attend school; and increased cost sharing between patients and insurers (e.g., higher
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premiums, deductibles, and co-payments/co-insurance).1–4 Predictably, financial toxicity can
yield a variety of negative effects on survivors’ quality of life, including increased risk for
bankruptcy, asset depletion, medical debt, and high levels of finance-related anxiety, worry,
and stress.5,6 Even among survivors who are insured, cost-coping strategies to reduce the
financial burden of cancer include depleting savings, borrowing money, failing to adhere to
prescribed treatment and medications, and delaying or forgoing follow-up care—all of
which can lead to overall lower quality of life, poor disease outcomes, and increased risk for
depression, anxiety, and distress.5,7–9 Rates of financial toxicity after cancer vary widely: a
recent systematic review found 12-62% of survivors report debt from treatment, 47-49%
report some level of cancer-related financial distress, and 4-45% report finance-related
medication nonadherence.5 Factors associated with financial toxicity include higher comorbidity, lower income at diagnosis, female gender, and younger age.3,4,10 Indeed, YA
survivors report cancer-related financial toxicity more frequently than older survivors.11–13
In the Adolescent and Young Adult Hope Study, a population-based cancer registry of
adolescent and young adults with cancer, 90% of young survivors reported a need for
financial support for medical care, and 62% wanted professional advice on managing
healthcare payments.11

Author Manuscript

A cancer diagnosis may interrupt key developmental transitions and milestones during
young adulthood, including educational pursuits and graduation, workforce entry/
advancement, and achieving financial independence from parents, and these interruptions
may limit survivors’ long-term earnings, contributing to financial toxicity.14–16 Survivors
may also face treatment-related cognitive, physical, and/or psychosocial impairments into
adulthood: over 50% of patients working or in school full-time before diagnosis report
problems with return to school/work after treatment because of issues with attention and
memory, missed days due to health or medical visits, and difficulty “keeping up.”12, 15
About a quarter of YA survivors have not returned to full-time school/work three years after
their diagnosis, and 12% report being “completely unable” to work at a job, do housework,
or go to school.12,15

Author Manuscript

Young survivors also face higher out-of-pocket medical costs than their peers, with current
estimates suggesting they spend, on average, an extra $3170 per year in medical costs over
non-survivors ($7417 vs $4247).15 Additionally, 44% of YA cancer survivors in their 20s,
and 26% in their 30s, report avoiding medical care because of its cost, compared to 16% and
18% in an age-matched non-cancer sample, respectively, with no difference in demographics
or insurance coverage between the two groups.17 YA cancer survivors are more likely to be
unable to afford medication (18.3% vs 11.9%; p<.002), request cheaper prescriptions (32.2%
vs 24.5%; p=.004), and use lower-cost alternative therapies (9.3% vs 5.4%; p=.01),
compared to peers.18
These effects may have very real consequences for survivors’ long-term financial outlook
and access to care. Compared to age-matched peers and siblings, YA survivors report lower
income and net worth, and they are more likely to be under- or unemployed, lack insurance
coverage or be covered by Medicaid, have debt, and declare bankruptcy.15,19,20 A recent
analysis found YA survivors are also more likely than siblings to experience “job lock,” in
which they stay in a job to maintain employer-sponsored medical coverage.10 This practice
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has the potential to limit survivors’ future earnings and career progress, and ultimately, as
the authors suggested, overall quality of life.10

Financial Costs of Family Building After Cancer
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Amidst cancer’s economic burden, YAs may also experience infertility, impaired fertility, or
other associated hurdles in pursuit of parenthood, which can result in additional costs when
trying to build their families. Due to the effects of gonadotoxic treatments, survivors may
need assisted reproductive technology (ART) to achieve pregnancy in the female partner/
survivor, using fresh, frozen, or donated gametes. If unable to carry a pregnancy, female
survivors may need to consider surrogacy with a gestational carrier. Alternatively, survivors
may choose to adopt a child. Each option has significant associated financial costs that may
cause or exacerbate cancer-related financial toxicity. These costs can be difficult to predict,
given uncertainty surrounding the exact procedures needed (e.g., number of in vitro
fertilization [IVF] cycles), the occurrence of unexpected medical costs, and the agency,
travel, and legal fees associated with adoption and surrogacy.21,22 In the U.S., cost estimates
range from $12,000–$15,000 per IVF cycle (or $40,000–$60,000 per live birth using IVF, as
patients often require multiple cycles) and $100,000–$150,000 for gestational carrier, with
limited insurance coverage available. Adoption cost estimates range from $30,000–$40,000
but depend on situational factors, such as domestic versus international adoption.23–27
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Financial assistance programs are available for patients seeking to undergo pre-treatment
fertility preservation to help offset costs of medication and egg/embryo or sperm storage. As
of this writing, only two states (Connecticut and Rhode Island) have mandated insurance
coverage laws for fertility preservation for cancer patients prior to initiation of cancerdirected therapy,28 with others (California, Hawaii, Maryland, Massachusetts, New York,
New Jersey) proposing similar measures. Financial assistance programs for post-treatment
family building, however, are largely non-existent. While it is possible to negotiate lower
rates with individual reproductive medicine centers, and there are a few opportunities to
apply for financial grants to support family building costs from patient organizations such as
The Samfund, these opportunities are limited. Thus, the onus for covering the majority of
family building costs when ART, surrogacy, or adoption is needed will likely fall upon the
YA survivor (and his/her partner).

Financial and Family Building Decision-Making

Author Manuscript

Given that YA cancer survivors rank fertility and family building as among their most
pressing post-treatment concerns and that fertility concerns can impact quality of life,29,30 it
is important to understand how survivors approach decisions and plan financially for ART,
surrogacy, and/or adoption, if needed. A number of factors may affect family building
decisions, including current reproductive health, prior fertility preservation, financial
resources, and the preferences and values of the prospective parents.31,32 Through an online
survey of 346 YA female cancer survivors, we previously demonstrated that uncertainty and
distress, measured as decisional conflict and concerns about reproduction, arise when
considering family building decisions after treatment and that higher decisional conflict was
influenced by unmet information needs (β = .43; p<.001).31 Few studies, however, have
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explored how cost or financial toxicity factors impact survivors’ decision-making or their
need for financial counseling.32,33 Although cost has been cited as a barrier to undergoing
fertility preservation before treatment,22,34 there is no indication that cancer or its financial
effects dissuade survivors (or their partners) from wanting to have children after cancer.35
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Given their age, it is also critical to consider that YAs may not yet possess the financial
aptitude to optimize decision-making and appropriately plan for post-treatment family
building costs. The Developmental Model of Financial Capability, which integrates concepts
from Developmental Theory, Social Cognitive Theory, and empirical findings related to
financial education and behaviors,36 posits that “financial capability” is a developmental
task, and increasing objective financial knowledge alone is not enough to change financial
behaviors. YA cancer survivors may also lack “health cost literacy,” or the ability to
understand financial concepts related to care, to discuss financial burden with clinicians as a
part of treatment decision-making, and to access appropriate resources to address financial
stress.37 This lack of knowledge and skills may lead YA survivors to make uninformed care
decisions, which can leave them unprepared for large bills or deductibles. To date, we are
unaware of any study that has explored YA survivors’ financial decision-making processes in
the context of family building after cancer therapy.
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For many survivors, achieving parenthood has significant potential to yield positive
outcomes, and decision-making about how to spend limited financial resources will depend
on individuals’ (and couples’) values, priorities, and goals. Our previous qualitative analysis
of financial difficulties related to family building suggests some survivors are willing to take
on significant economic burden and debt to achieve parenthood, while others are surprised
and unprepared for the costs they incur.35 In both scenarios, we found that prospective
parents are often anxious about the long-term implications of the financial steps taken to
cover costs (e.g., depleting savings and assets, incurring debt), particularly as they prepare
for the cost of a new child.35 These data suggest the importance of ensuring survivors
receive adequate information to make informed decisions about family building, so they may
plan for the associated costs, as needed. Financial planning strategies could potentially
mitigate long-term financial strain and distress and allow survivors to avoid unexpected bills.
We propose the need for comprehensive support services to help YA cancer survivors make
decisions about family building options, including strategies to promote financial capability,
health cost literacy, and early financial planning.

Tailoring Interventions
Author Manuscript

Recently, various stakeholders in cancer care, including healthcare systems/providers,
pharmaceutical companies, payers, and patient advocacy groups, have sought to address the
financial toxicity related to cancer treatment. Proposed interventions at a systemic level
include lowering the price of drugs, allowing the Centers for Medicare and Medicaid
Services to negotiate costs, and addressing the proportion of costs that fall to patients.
However, it is unlikely that such policy changes will be implemented in the foreseeable
future.38
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Oncologists and allied health providers can become key players in addressing the immediacy
of financial toxicity, a responsibility the oncology care community has acknowledged.39 The
role of the provider should include discussing treatment costs with patients and referring to
support services for financial assistance as needed.
The need for providers to educate patients and/or make referrals to financial support services
extends to fertility-related services as well, and it is critical for providers to initiate these
discussions early enough to ensure patients have time to prepare before they are ready to
start a family.38 Although research has shown that over half (52%) of patients want to
discuss financial issues with their care providers,61 medical professionals are often
uncomfortable and ill-prepared to have financial discussions. Empirically-based resources
are needed to facilitate financial discussions and support providers in assessing patients’
need for financial support and in making appropriate referrals.

Author Manuscript

Potential strategies to support these discussions include patient navigation services, peer-topeer mentoring, and topic-specific support groups for patients interested in post-treatment
family building options. While financial navigation interventions are being tested in the
research setting,40 we are not aware of any targeted toward YA cancer survivors, despite data
highlighting this group’s interest in such interventions.41 Likewise, general interventions
focusing on post-treatment fertility preservation and family building decisions are limited;
the majority of research in this area has focused on fertility preservation decisions before
treatment begins,42–47 and to our knowledge, none have included financial counseling or
educational content aimed at building financial skills. We are also unaware of any existing
decision support interventions regarding fertility preservation or family building decisions
for males.48
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Ideal interventions targeting family building and financial toxicity should thus focus on
providing basic information about the healthcare and insurance systems; detailing expected
costs in the treatment and survivorship settings, highlighting the potential for unforeseen
expenditures; educating patients on the skills needed to navigate current and future finances;
and instructing survivors about the intersection between financial toxicity and family
building costs. In the pre-treatment setting, financially-focused fertility information should
address the short-term costs associated with fertility preservation, including medication and
retrieval procedures, as well as the long-term costs associated with gamete/embryo freezing
and storage; the eventual use of the specimens, be it through the survivor’s (or partner’s)
own pregnancy or surrogacy; and/or adoption. In the post-treatment setting, topics should
include the costs associated with post-treatment fertility preservation (if applicable); use of
previously stored gametes/embryos; and alternative family building options such as
adoption. In both settings, it is vital for these discussions to occur within the context of the
survivor’s ongoing medical care and healthcare costs, and with consideration for the
survivor’s developmental age and for the effects of treatment on his or her ability to work or
attend school.41 It is equally important for the patient to evaluate and incorporate his or her
values related to finances and family building into the conversation.
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Next Steps
The long-term psychosocial burden of cancer-related fertility problems is well-established,
and addressing fertility is now considered a key aspect of cancer care.31,49–52 As such,
leading medical organizations have issued guidelines highlighting the need for clinicians to
inform patients about their risks of infertility, discuss options for fertility preservation, and
refer interested patients to reproductive specialists before treatment begins.53–57 Importantly,
issues surrounding fertility, reproductive health, and family building must be revisited posttreatment as well, as a lack of fertility-specific information, misconceptions, anxiety, and
distress are common in this population.58–60

Author Manuscript

Further work is needed to examine YA cancer survivors’ financial capability and the impact
of financial knowledge, perceptions, and practices on family building decisions and financial
outcomes. This can lead to the development of evidence-based resources to help survivors
manage the financial effects of cancer and make decisions about family building. While
several decision support interventions have been developed for pre-treatment fertility
preservation, we argue that similar support services are needed in the post-treatment setting.
This support may help mitigate undue financial burden and the exacerbation of subsequent
financial toxicity and its psychosocial impact while ensuring patients have the opportunity to
make informed, values-based decisions regarding family building and plan and prepare for
the associated costs of ART, surrogacy, and adoption.
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